Cutaneous lupus erythematosus: a review (Q30309818)

16 June 2017

1 reference

title

Cutaneous lupus erythematosus: a review (English)

1 reference

cutaneous lupus erythematosus

16 June 2017

1 reference

Purvisha Patel

1

1 reference

PubMed ID

12170873

16 June 2017

Victoria Werth

series ordinal

2

1 reference

16 June 2017

1 July 2002

1 reference

16 June 2017

1 reference

16 June 2017

20

1 reference

16 June 2017

3

1 reference

16 June 2017

373-85, v

1 reference

Epidemiology and socioeconomic impact of skin disease in lupus erythematosus

16 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Genetic and immunological mechanisms in the pathogenesis of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Familial lupus erythematosus. Clinical and immunologic features of 125 multiplex families

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

A genome-wide search for susceptibility genes in human systemic lupus erythematosus sib-pair families

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Molecular genetics of cutaneous lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1q in African-American pedigrees

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Genome-wide screen for systemic lupus erythematosus susceptibility genes in multiplex families

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Cutaneous lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Pathogenetic mechanisms and treatment of cutaneous lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Subacute cutaneous lupus erythematosus in multiple members of a family with C2 deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Homozygous C2 deficiency, lupus erythematosus, and anti-Ro (SSA) antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Hereditary deficiency of C5 in association with discoid lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Generalized lupus erythematosus profundus in a patient with genetic partial deficiency of C4

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Systemic lupus erythematosus in hereditary deficiency of the fourth component of complement

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Complement deficiency and immune complex disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Lupus erythematosus associated with genetically determined deficiency of the second component of the complement

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Polymorphic MHC ancestral haplotypes affect the activity of tumour necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

In vitro cytokine production by HLA-B8,DR3 positive subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-a and TNF-0 by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Association of a Promoter Polymorphism of Tumor Necrosis Factor-α with Subacute Cutaneous Lupus Erythematosus and Distinct Photoregulation of Transcription1,21Werth VP, Sullivan K: Strong association of a promoter polymorphism of tumor necrosis fact

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Relationship between heat shock protein induction and the binding of antibodies to the extractable nuclear antigens on cultured human keratinocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Analysis of 70 KD heat shock protein (HSP70) expression in the lesional skin of lupus erythematosus (LE) and LE related diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Phototesting and photoprotection in LE.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Photosensitivity in lupus erythematosus, UV photoprovocation results compared with history of photosensitivity and clinical findings

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Expression of SS-A/Ro and SS-B/La antigens in skin biopsy specimens of patients with photosensitive forms of lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Ultraviolet light-induced keratinocyte apoptosis: a potential mechanism for the induction of skin lesions and autoantibody production in LE.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Ultraviolet-B-Induced Apoptosis of Keratinocytes: Evidence for Partial Involvement of Tumor Necrosis Factor-α in the Formation of Sunburn Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Keratinocyte apoptosis and p53 expression in cutaneous lupus and dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

DNA-dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Proteins phosphorylated during stress-induced apoptosis are common targets for autoantibody production in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

The cutaneous pathology of lupus erythematosus: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Genesis and evolution of antichromatin autoantibodies in murine lupus implicates T-dependent immunization with self antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Keratinocytes from patients with lupus erythematosus show enhanced cytotoxicity to ultraviolet radiation and to antibody-mediated cytotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Photosensitivity diseases: cutaneous lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Subacute cutaneous lupus erythematosus associated with cilazapril

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Subacute cutaneous lupus erythematosus arising in the setting of calcium channel blocker therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Thiazide diuretics induce cutaneous lupus-like adverse reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Subacute cutaneous lupus erythematosus associated with hydrochlorothiazide therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Subacute cutaneous lupus erythematosus associated with hydrochlorothiazide therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Subacute cutaneous lupus erythematosus: a decade's perspective.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Subacute cutaneous lupus erythematosus associated with interferon beta-1a

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

A distinctive eruption in patients receiving oxprenolol

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Terbinafine-induced subacute cutaneous lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Subacute cutaneous lupus erythematosus lesions precipitated by griseofulvin

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Systemic lupus erythematosus exacerbated by piroxicam

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Cutaneous lupus erythematosus following laser-induced thermal injury

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

In situ expression of B7 and CD28 receptor families in skin lesions of patients with lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Dermal fibroblasts sustain proliferation of activated T cells via membrane-bound interleukin-15 upon long-term stimulation with tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Detection of Type 1 Cytokines in Discoid Lupus Erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Distribution of naive and memory T-cells in photoprovoked and spontaneous skin lesions of discoid lupus erythematosus and polymorphous light eruption.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Determinant spreading: lessons from animal models and human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Apoptosis in different cutaneous manifestations of lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Expression of Fas antigen on keratinocytes in vivo and induction of apoptosis in cultured keratinocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Ultraviolet light modulation of autoantigens, epidermal cytokines and adhesion molecules as contributing factors of the pathogenesis of cutaneous LE.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Cytokine-induced ICAM-1 expression in human keratinocytes is highly variable in keratinocyte strains from different donors

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

VCAM-1 expression on endothelium in lesions from cutaneous lupus erythematosus is increased compared with systemic and localized scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Elevated soluble E-selectin in cutaneous lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

The use of laboratory tests in the diagnosis of SLE

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Problems of disability and rehabilitation in patients with chronic skin diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Epidemiology of cutaneous lupus erythematosus in a tertiary referral centre in Singapore

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

The specificity and clinical usefulness of the lupus band test

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

The immunofluorescent "band" test for lupus erythematosus. 3. Employing clinically normal skin

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Skin Immunofluorescence Studies on Lupus Erythematosus and Other Antinuclear-Antibody-Positive Diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

A Reappraisal of the Relationship between Subepidermal Immunoglobulin Deposits and DNA Antibodies in Systemic Lupus Erythematosus: A Study Using the Crithidia Luciliae Immunofluorescence Anti-DNA Assay

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

The significance of a positive cutaneous immunofluorescence test in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

An immunofluorescence study of lichen planus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Cutaneous Immunopathology: Recent Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

The scope and limitations of the immunofluorescence method in the diagnosis of lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Uncommon cutaneous manifestations of lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Verrucous lupus erythematosus: ultrastructural studies on a distinct variant of chronic discoid lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Atypical lymphoid infiltrates arising in cutaneous lesions of connective tissue disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Lupus erythematosus tumidus--a neglected subset of cutaneous Lupus erythematosus: report of 40 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Tumid lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Clinical, histological and immunopathological features of 58 patients with subacute cutaneous lupus erythematosus. A review by the Italian group of immunodermatology

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Subacute cutaneous lupus erythematosus with pityriasis-like cutaneous manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Subacute cutaneous lupus erythematosus presenting with generalized poikiloderma

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Drug treatment of cutaneous lupus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Counterimmunoelectrophoresis, ELISA and immunoblotting detection of anti-Ro/SSA antibodies in subacute cutaneous lupus erythematosus. A comparative study

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Dermatological aspects of SLE, especially regarding the ARA (ARC) criteria

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Is subacute cutaneous lupus erythematosus a subset of systemic lupus erythematosus or a distinct entity?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Dust-like particles: a specific direct immunofluorescence pattern in sub-acute cutaneous lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

The significance of the 'dust-like particles' pattern of immunofluorescence. A study of 66 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Bullous systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Pathology, immunopathology, and immunohistochemistry in cutaneous lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Ultraviolet radiation protection factors for clothing

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Cutaneous lupus erythematosus-treatment with pulsed dye laser

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Pulsed dye laser treatment of subacute cutaneous lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Successful treatment of discoid lupus erythematosus with argon laser

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Carbon dioxide laser resurfacing of facial scarring secondary to chronic discoid lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Nonoperative techniques for scar management and revision

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Discoid lupus erythematosus lesions treated with cryosurgery

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Chloroquine: consideration of maximum daily dose (3.5 mg/kg ideal body weight) prevents retinopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Patients with cutaneous lupus erythematosus who smoke are less responsive to antimalarial treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Resistant discoid lupus erythematosus of palms and soles: successful treatment with azathioprine

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Management of cutaneous lupus erythematosus with low-dose methotrexate: indication for modulation of inflammatory mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Rapid improvement of subacute cutaneous lupus erythematosus with low-dose methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Methotrexate for the treatment of discoid lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Discoid lupus erythematosus: successful treatment with oral methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Cytarabine therapy for refractory cutaneous lupus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Maintaining remission of lupus erythematosus profundus (LEP) with cyclosporin A

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

High-dose intravenous immunoglobulin in cutaneous lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

High-dose intravenous immunoglobulins: an approach to treat severe immune-mediated and autoimmune diseases of the skin

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Experience with low-dose thalidomide therapy in chronic discoid lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Thalidomide: current and potential clinical applications

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Clinical and immunologic parameters during thalidomide treatment of lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

American experience with low-dose thalidomide therapy for severe cutaneous lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Thalidomide induces amenorrhea in patients with lupus disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Pustuloderma during cutaneous lupus treatment with thalidomide

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Dapsone in the treatment of cutaneous lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Further Study of the Use olf Clolaziinine in Discoid Lupus Erytheniatosus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Treatment of cutaneous lupus erythematosus with acitretin and hydroxychloroquine

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Review: Treatment of Cutaneous Lupus Erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Treatment of severe cutaneous lupus erythematosus with a chimeric CD4 monoclonal antibody, cM-T412

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Response of discoid and subacute cutaneous lupus erythematosus to recombinant interferon alpha 2a

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Long-term cefuroxime axetil in subacute cutaneous lupus erythematosus. A report of three cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

Musculoskeletal and systemic reactions to biological therapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

A candidate gene analysis of three related photosensitivity disorders: cutaneous lupus erythematosus, polymorphic light eruption and actinic prurigo

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900016-5

7 January 2021

10.1016/S0733-8635(02)00016-5

Identifiers

DOI

1 reference

16 June 2017

1 reference

PubMed ID

12170873